SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
SHAC was delisted on the 9th of December, 2022.
68 hedge funds and large institutions have $188M invested in SCP & CO Healthcare Acquisition Company Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 7 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
1% more capital invested
Capital invested by funds: $185M → $188M (+$2.46M)
0% more funds holding
Funds holding: 68 → 68 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$10.1M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$7.12M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3.9M |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$1.56M |
| 5 |
Barclays
London,
United Kingdom
|
+$1.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$17M |
| 2 |
Blackstone Inc
New York
|
-$3.92M |
| 3 |
HIH
HRS Investment Holdings
New York
|
-$2.94M |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.96M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.63M |
SHAC Hedge Fund Activity: Q1 2022 in Review
68 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) for Q1 2022, worth a combined $188M — up 1.3% from $185M a quarter earlier.
Fund positioning in SHAC was balanced in Q1 2022: 7 funds opened new positions, 7 closed out, 16 added to existing stakes and 6 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $10.1M. The largest seller was UBS O'Connor, exiting entirely with an estimated $17M sold.
- 68 institutional investors held SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $188M of SCP & CO Healthcare Acquisition Company Class A Common Stock stock for Q1 2022, up 1.3% quarter-over-quarter.
- 7 funds opened new SCP & CO Healthcare Acquisition Company Class A Common Stock positions in Q1 2022 and 7 closed out, a net change of 0 holders.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock buyer in Q1 2022 was Aristeia Capital, an estimated $10.1M added.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $17M sold.
Based on aggregated 13F filings for Q1 2022.